cytoreductive surgery (CRS)
Showing 1 - 25 of >10,000
Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)
Not yet recruiting
- Ovarian Cancer
- Drug Related Neoplasm/Cancer
- secondary cytoreductive surgery
- chemotherapy
- (no location specified)
Jan 28, 2023
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)
Recruiting
- Stage III Ovarian Cancer
- +6 more
- Cytoreductive Surgery (CRS)
- +6 more
-
Baltimore, MarylandMercy Medical Center
Aug 30, 2022
Appendix Cancer, Colorectal Cancer Trial in United States (Cytoreductive Surgery, HIPEC with Mitomycin-C, EPIC with FUDR and
Recruiting
- Appendix Cancer
- Colorectal Cancer
- Cytoreductive Surgery
- +2 more
-
Miami, Florida
- +8 more
Jan 12, 2023
Pseudomyxoma Peritonei Trial in Milano (Capecitabine)
Recruiting
- Pseudomyxoma Peritonei
-
Milano, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022
Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemo, Peritoneal Cancer Trial in Seoul (Arm I (QL block and multimodal
Recruiting
- Cytoreductive Surgery
- +2 more
- Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Dec 2, 2022
An Audit of Cytoreductive Surgery and Hyperthermic
Recruiting
- Colorectal Cancer
- +2 more
- Hyperthermic intraperitoneal chemotherapy
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Apr 25, 2022
Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemo, Hydration Trial in Beijing (Urine-guided hydration, Routine
Not yet recruiting
- Cytoreductive Surgery
- +5 more
- Urine-guided hydration
- +3 more
-
Beijing, ChinaAerospace Center Hospital
Jul 11, 2023
Gastric Cancer With Peritoneal Metastasis (PCI<12) Trial in Seoul (CRS+HIPEC)
Recruiting
- Gastric Cancer With Peritoneal Metastasis (PCI<12)
-
Seoul, Korea, Republic ofDepartment of Surgery, Yonsei University College of Medicine
Apr 21, 2022
Peritoneal Carcinomatosis Trial in Villejuif (Pasireotide 0.9 MG/ML, Saline water)
Recruiting
- Peritoneal Carcinomatosis
- Pasireotide 0.9 MG/ML
- Saline water
-
Villejuif, FranceGustave Roussy
Mar 29, 2021
Colorectal Tumors, Colorectal Cancer, Colorectal Cancer Metastatic Trial in Guangzhou (Preoperative systematic therapy,
Not yet recruiting
- Colorectal Neoplasms
- +8 more
- Preoperative systematic therapy
- +2 more
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital of Sun Yat-sen University
Apr 28, 2022
Malignant Tumor of Stomach, Secondary Malignant Tumor of Peritoneum, Secondary Malignant Tumor of Other and Unspecified Sites
Completed
- Malignant Neoplasm of Stomach
- +2 more
- HIPEC
-
Berlin, GermanyKlinik für Allgemein-, Visceral-, Gefäß- und ThoraxchirurgieChar
Jul 28, 2021
Peritoneal Cancer Trial in Houston (Local Anesthetic Solution, Bupivacaine HCl, Liposomal Bupivacaine)
Completed
- Peritoneal Cancer
- Local Anesthetic Solution
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 27, 2022
Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)
Recruiting
- Peritoneal Carcinomatosis
- Mitomycin C, flat dose 40 mg
- Mitomycin C, weight-based dose 12.5 mg/m2
-
Lexington, KentuckyUniversity of Kentucky
Mar 1, 2022
Gastric Cancer, Peritoneal Carcinomatosis Trial in Taipei (CRS followed by IP and systemic chemotherapies)
Recruiting
- Gastric Cancer
- Peritoneal Carcinomatosis
- CRS followed by IP and systemic chemotherapies
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 19, 2022
ERAS® Guidelines Validation of CRS With or Without HIPEC
Recruiting
- Peritoneal Diseases
- Pre-ERAS® phase (current clinical practice)
- Post-ERAS® implementation phase
-
Dallas, Texas
- +2 more
Dec 22, 2021
Ileus Trial in La Jolla (Alvimopan, Placebo)
Ovarian Cancer, Ovary Tumor, Ovarian Tumors Trial in Wuhan (HIPEC, CRS, IVCT)
Active, not recruiting
- Ovarian Cancer
- +5 more
- HIPEC
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
May 28, 2020
Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy
Completed
- Ovarian Cancer
- Cytoreductive Surgery (CRS)
- +4 more
- (no location specified)
Mar 17, 2021
Colorectal Tumor, Colorectal Cancer, Colorectal Tumors Malignant Trial in Belgium, Netherlands (other, combination product,
Recruiting
- Colorectal Neoplasm
- +10 more
- Perioperative systemic therapy
- +5 more
-
Genk, Vlaanderen, Belgium
- +8 more
Jul 28, 2021
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Cytoreductive Surgery Trial in Hangzhou (cytoreductive surgery)
Not yet recruiting
- Cytoreductive Surgery
- cytoreductive surgery
-
Hangzhou, China
- +1 more
Nov 30, 2022
Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)
Completed
- Peritoneal Cancer
- +7 more
- nanoliposomal irinotecan
-
Lexington, Kentucky
- +1 more
May 5, 2022
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Recruiting
- Peritoneal Carcinomatosis
-
Regensburg, Bavaria, Germany
- +1 more
Nov 29, 2020
Severe Neutropenia After HIPEC Using Mitomycin-C
Recruiting
- Colorectal Cancer Metastatic
- +3 more
- Intraoperative blood and peritoneal fluid samplings during HIPEC
-
Seoul, Korea, Republic ofDivision of Colon and Rectal Surgery, Department of Surgery, Gan
Aug 21, 2022
Ovarian Cancer Trial in Goyang (Cisplatin)
Not yet recruiting
- Ovarian Cancer
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center
Apr 24, 2023